<?xml version="1.0" encoding="UTF-8"?>
<ref id="B10-viruses-12-00276">
 <label>10.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Margine</surname>
    <given-names>I.</given-names>
   </name>
   <name>
    <surname>Krammer</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Hai</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Heaton</surname>
    <given-names>N.S.</given-names>
   </name>
   <name>
    <surname>Tan</surname>
    <given-names>G.S.</given-names>
   </name>
   <name>
    <surname>Andrews</surname>
    <given-names>S.A.</given-names>
   </name>
   <name>
    <surname>Runstadler</surname>
    <given-names>J.A.</given-names>
   </name>
   <name>
    <surname>Wilson</surname>
    <given-names>P.C.</given-names>
   </name>
   <name>
    <surname>Albrecht</surname>
    <given-names>R.A.</given-names>
   </name>
   <name>
    <surname>Garcia-Sastre</surname>
    <given-names>A.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses</article-title>
  <source>J. Virol.</source>
  <year>2013</year>
  <volume>87</volume>
  <fpage>10435</fpage>
  <lpage>10446</lpage>
  <pub-id pub-id-type="doi">10.1128/JVI.01715-13</pub-id>
  <pub-id pub-id-type="pmid">23903831</pub-id>
 </element-citation>
</ref>
